| Trial ID: | L3510 |
| Source ID: | NCT00934414
|
| Associated Drug: |
Technosphere Insulin Inhalation Powder
|
| Title: |
Clamp Study Comparing Inhalation of Technosphere®/Insulin in Smokers and Non-Smokers With Type 2 Diabetes
|
| Acronym: |
|
| Status: |
COMPLETED
|
| Study Results: |
NO
|
| Results: |
|
| Conditions: |
Diabetes Type 2
|
| Interventions: |
DRUG: Technosphere Insulin Inhalation Powder
|
| Outcome Measures: |
Primary: To compare the relative bioavailability and bioeffect of TI Inhalation Powder in subjects with type 2 diabetes who smoke and who do not smoke to determine relative insulin bioavailability, 15 to 52 days |
|
| Sponsor/Collaborators: |
Sponsor: Mannkind Corporation
|
| Gender: |
ALL
|
| Age: |
ADULT, OLDER_ADULT
|
| Phases: |
PHASE2
|
| Enrollment: |
24
|
| Study Type: |
INTERVENTIONAL
|
| Study Designs: |
Allocation: NON_RANDOMIZED|Intervention Model: PARALLEL|Masking: NONE|Primary Purpose: TREATMENT
|
| Start Date: |
2004-08
|
| Completion Date: |
2006-09
|
| Results First Posted: |
|
| Last Update Posted: |
2009-07-08
|
| Locations: |
Profil Institute for Clinical Research, Chula Vista, California, 91911, United States
|
| URL: |
https://clinicaltrials.gov/show/NCT00934414
|
